Just recently Johnson and Johnson stated they too were considering selling branded generics abroad overseas. I think with technology and drug R and D being on the fast track, patents today and in the future may not enjoy the same time frames as have been granted in the past, again due to economics...
The Medical Quack .... by Barbara Duck
The Medical Quack
Fri, Jun 26 2009
Filed under: Filed under: Medically Related, Pharma/FDA News, healthcare, Prescriptions, Generic Drugs, Merck, Economy, Patents, Johnson and Johnson, Teva, Sanofi-Aventis, cheap drugs